Coronavirus hospital admissions increased 12. 5% in the week ending July 29
Find your favorites in your Premium section Independent, my profile
Summer piles up on Covid-19 hospitalizations in the U. S.
A new variant of covid-19 that now accounts for nearly one-fifth of cases in the U. S. U. S. It’s causing a slight increase in hospitalizations, fitness officials warned.
Officially as EG5, the strain accounted for 17. 3% of U. S. cases. UU. al August 5, compared to 7. 5% in the first week of July and surpassing several descendants of Omicron such as XBB. 1. 16 (15. 6% of cases), XBB. 2. 23 (11. 2%) and XBB. 1. 5 (10. 3%).
The emergence of the EG5 strain comes at a time when the U. S. is not yet in the U. S. U. S. hospitals are experiencing an increase in coronavirus hospital admissions, their first significant increase since December 2022.
The Centers for Disease Control and Prevention (CDC) recorded a 12. 5% increase in the week ending July 29, as another 9,056 people lost their breath nationwide, likely due to summer socialization, decreased immunity and allowable precautions. . expire.
“It’s speeding up a little bit, but it’s not something we want to sound the alarm about,” Dr. David Dowdy, an infectious disease epidemiologist at the Johns Hopkins Bloomberg School of Public Health, told The Associated Press.
The CDC’s next tranche of bi-weekly issues will further remove the darkness of the hole extent when they are released in the coming days.
However, awareness is limited as many states stopped reporting case rates when the Biden administration ended the Covid public fitness emergency in May.
About 500 to 600 more people in the U. S. have died a week from covid since June, according to the CDC.
A social media thread by Professor T Ryan Gregory of the University of Guelph in Ontario, Canada, warned of the risk posed by a subvariant of the lineage, EG5. 1, dubbed it “Eris” and sparked renewed fear about the prospect. Rebound in infections.
Professor Gregory said EG5. 1 “is not super remarkable in terms of rapid mutations and is not even the fastest new XBB variant, but its frequency is expanding and needs to be monitored even if it is not expected to cause a giant wave. “
The World Health Organization (WHO) placed the EG5 line on its list of “variants under surveillance” on July 19 and dated its first documented samples to February 17 this year, underscoring the relative speed of its emergence since its discovery in Indonesia that month. .
Experts have warned that the line benefits from a “slight mutation” that gives it an edge over its competing variants as it seeks to expand.
An electron microscope symbol from the U. S. National Institutes of Health. The U. S. drug show the new coronavirus emerging from the surface of cells.
They also recommend that there is little difference in symptoms and severity among the other strains circulating lately, although they admit that it is becoming increasingly difficult to distinguish sophisticated deviations, as virus surveillance is much less thorough than at the height of the pandemic. . .
In the UK, where Eris has also made headway, Zoe’s health study said her symptoms are similar to Omicron’s, which come with runny or stuffy nose, headache, fatigue, sneezing, sore throat, cough and adjustments in the patient. sense. smell.
The CDC’s recommendation on what to do if you want to refer a positive result to a side check has not changed, and citizens are asked to stay home and isolate themselves from others in a well-ventilated space, wear a mask when meeting with others, practice good hygiene, Get plenty of rest and look for over-the-counter pharmaceutical remedies to help control symptoms.
It’s also to stay on top of vaccinations and boosters, which were changed again to counter the latest strains in time for the fall flu season.
“While the covid emergency was lifted and we are no longer in a crisis phase, the risk of covid has not disappeared. Therefore, surveillance follow-up and sequencing remain essential,” said Dr. Stuart. Maria Van Kerkhove, WHO technical lead for the virus. At a press conference on July 26, a timely reminder that it still poses a danger, even if we prefer it.
Join interesting conversations, other independent readers and see their answers
An electron microscope symbol from the U. S. National Institutes of Health. The U. S. drug show the new coronavirus emerging from the surface of cells.
An electron microscope symbol from the U. S. National Institutes of Health. The U. S. drug show the new coronavirus emerging from the surface of cells.
Pennsylvania
Want to bookmark your favorite articles and stories to read or refer to later?Start your Premium Independent club today.